AbbVie

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. 

CEO
Richard A. Gonzalez
CEORichard A. Gonzalez
Employees
50,000
Employees50,000
Headquarters
North Chicago, Illinois
HeadquartersNorth Chicago, Illinois
Founded
2011
Founded2011
Employees
50,000
Employees50,000

ABBV Key Statistics

Market cap
293.95B
Market cap293.95B
Price-Earnings ratio
49.55
Price-Earnings ratio49.55
Dividend yield
3.64%
Dividend yield3.64%
Average volume
4.67M
Average volume4.67M
High today
$166.50
High today$166.50
Low today
$163.89
Low today$163.89
Open price
$164.69
Open price$164.69
Volume
5.15M
Volume5.15M
52 Week high
$182.89
52 Week high$182.89
52 Week low
$130.96
52 Week low$130.96

ABBV News

Benzinga 1d
The Analyst Verdict: AbbVie In The Eyes Of 5 Experts - AbbVie - Benzinga

Loading... Loading... 5 analysts have expressed a variety of opinions on AbbVie ABBV over the past quarter, offering a diverse set of opinions from bullish to...

The Analyst Verdict: AbbVie In The Eyes Of 5 Experts - AbbVie - Benzinga
Yahoo Finance 2d
AbbVie CEO latest heavy hitter to buy in Boca Raton - Yahoo Finance

AbbVie's Richard Gonzalez with 650 Tern Point Circle in Boca Raton (Daniel Petroni, AbbVie) AbbVie CEO Richard Gonzalez is the latest heavy hitter to buy in Bo...

AbbVie CEO latest heavy hitter to buy in Boca Raton - Yahoo Finance
Benzinga 2d
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pha...

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game

Analyst ratings

60%

of 30 ratings
Buy
60%
Hold
40%
Sell
0%

More ABBV News

TipRanks 4d
AbbVie, Gilgamesh Pharmaceuticals to co-develop psychiatric disorder therapies - TipRanks.com - TipRanks

AbbVie and Gilgamesh Pharmaceuticals announced a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. T...

Benzinga 4d
Unpacking the Latest Options Trading Trends in AbbVie - AbbVie - Benzinga

Loading... Loading... Deep-pocketed investors have adopted a bearish approach towards AbbVie ABBV, and it's something market players shouldn't ignore. Our trac...

Unpacking the Latest Options Trading Trends in AbbVie - AbbVie - Benzinga
Yahoo Finance 4d
AbbVie Boosts Neuropsychiatric Portfolio With New Deal - Yahoo Finance

AbbVie Inc. ABBV announced that it has signed a collaboration and option-to-license agreement with New York-based privately held biotech Gilgamesh Pharmaceutica...

AbbVie Boosts Neuropsychiatric Portfolio With New Deal - Yahoo Finance
Yahoo Finance 4d
Investors Heavily Search AbbVie Inc.: Here is What You Need to Know - Yahoo Finance

AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the ne...

Investors Heavily Search AbbVie Inc.: Here is What You Need to Know - Yahoo Finance
Seeking Alpha 5d
AbbVie, Gilgamesh to develop next-generation psychedelic drugs

AbbVie (NYSE:ABBV) has signed a collaboration and option-to-license agreement with Gilgamesh Pharmaceuticals to develop next-generation psychedelic drugs for th...

AbbVie, Gilgamesh to develop next-generation psychedelic drugs
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.